INBS

Intelligent Bio Solutions Inc. Common Stock

1.68

USD

+0.01

+0.30%

Oct 29, 10:33 UTC -4

Open

Intelligent Bio Solutions Inc. Common Stock (INBS) Earnings

INBS Earnings Reports

Positive Surprise Ratio

INBS beat 6 of 11 last estimates.

55%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q4 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Intelligent Bio Solutions Inc. Common Stock earnings per share and revenue

On Aug 19, 2026, INBS reported earnings of -0.90 USD per share (EPS) for Q4 26, beating the estimate of -1.61 USD, resulting in a 44.15% surprise. Revenue reached 1.15 million, compared to an expected 1.24 million, with a -7.91% difference. The market reacted with a -17.08% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Danaher Corporation

Report Date

Oct 21, 2026 For Q3 26

Estimate

$1.93

Actual

$2.11

Surprise

+8.99%

HCA Healthcare, Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$6.72

Actual

$7.22

Surprise

+7.29%

Elevance Health, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$4.72

Actual

$6.99

Surprise

+47.81%

Labcorp Holdings Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$4.79

Actual

$4.78

Surprise

-0.31%

Medpace Holdings, Inc. Common Stock

Report Date

Oct 21, 2026 For Q3 26

Estimate

$4.52

Actual

$4.84

Surprise

+6.98%

Icon Plc

Report Date

Oct 27, 2026 For Q3 26

Estimate

$2.65

Actual

$2.66

Surprise

+0.27%

Avantor, Inc.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.21

Actual

$0.22

Surprise

+3.92%

Bausch + Lomb Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.22

Actual

$0.34

Surprise

+53.43%

Pediatrix Medical Group, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.66

Actual

$0.72

Surprise

+7.61%

Establishment Labs Holdings Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

-$0.26

Actual

-$0.35

Surprise

-33.69%

FAQ

What were Intelligent Bio Solutions Inc. Common Stock's earnings and revenue for the latest quarter Q4 2026?

For Q4 2026, Intelligent Bio Solutions Inc. Common Stock reported EPS of -$0.90, beating estimates by 44.15%, and revenue of $1.15M, -7.91% below expectations.

How did the market react to Intelligent Bio Solutions Inc. Common Stock's Q4 2026 earnings?

The stock price moved down -17.08%, changed from $3.22 before the earnings release to $2.67 the day after.

When is Intelligent Bio Solutions Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Intelligent Bio Solutions Inc. Common Stock's next earnings report?

Based on -- analysts, Intelligent Bio Solutions Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.